Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.
Rebold N, Morrisette T, Lagnf AM, Alosaimy S, Holger D, Barber K, Justo JA, Antosz K, Carlson TJ, Frens JJ, Biagi M, Kufel WD, Moore WJ, Mercuro N, Raux BR, Rybak MJ.
Rebold N, et al. Among authors: holger d.
Open Forum Infect Dis. 2021 Dec 9;8(12):ofab554. doi: 10.1093/ofid/ofab554. eCollection 2021 Dec.
Open Forum Infect Dis. 2021.
PMID: 34901302
Free PMC article.